agilon health Inc (AGL)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-12-13 | 2024-12-13 | B Purchase | Non-Executive Director |
25,000
+51.9%
2.20USD 55,085 |
25,000 +51.9% | 2.20 | USD 55,085 | |
| 2024-12-13 | 2024-12-11 | B Purchase | Non-Executive Director |
25,062
+61.0%
2.01USD 50,269 |
25,062 +61.0% | 2.01 | USD 50,269 | |
| 2024-12-11 | 2024-12-09 | B Purchase | Non-Executive Director |
7,500
+14.6%
2.20USD 16,489 |
7,500 +14.6% | 2.20 | USD 16,489 | |
| 2024-12-11 | 2024-12-05 | B Purchase | Non-Executive Director |
45,000
+27.9%
2.18USD 98,145 |
45,000 +27.9% | 2.18 | USD 98,145 | |
| 2024-12-11 | 2024-11-25 | B Purchase | Non-Executive Director |
12,500
+32.2%
2.28USD 28,474 |
12,500 +32.2% | 2.28 | USD 28,474 | |
| 2024-09-16 | 2024-09-12 | B Purchase |
CEO & President Executive Director |
20,000
+42.0%
3.36USD 67,188 |
20,000 +42.0% | 3.36 | USD 67,188 | |
| 2024-03-18 | 2024-03-14 | B Purchase |
Chief Technology Officer Officer |
5,434
0.00USD 0 |
5,434 | 0.00 | USD 0 | |
| 2024-03-18 | 2024-03-14 | B Purchase |
Chief Financial Officer Officer |
14,945
0.00USD 0 |
14,945 | 0.00 | USD 0 | |
| 2024-03-18 | 2024-03-14 | B Purchase |
Chief Markets Officer Officer |
274,455
0.00USD 0 |
274,455 | 0.00 | USD 0 | |
| 2024-03-18 | 2024-03-14 | B Purchase |
Chief Med. & Quality Officer Officer |
5,434
0.00USD 0 |
5,434 | 0.00 | USD 0 | |
| 2024-03-18 | 2024-03-14 | B Purchase |
Chief Strategy & Dev. Officer Officer |
11,956
0.00USD 0 |
11,956 | 0.00 | USD 0 | |
| 2023-11-30 | 2023-11-29 | B Purchase | Non-Executive Director |
22,300
+231.5%
11.22USD 250,206 |
22,300 +231.5% | 11.22 | USD 250,206 | |
| 2023-11-21 | 2023-11-21 | B Purchase |
CEO & President Executive Director |
44,690
+1541.0%
11.14USD 497,739 |
44,690 +1541.0% | 11.14 | USD 497,739 | |
| 2023-09-14 | 2023-09-13 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-19.1%
18.00USD 337,455 |
18,750 -19.1% | 18.00 | USD 337,455 | |
| 2023-09-14 | 2023-09-12 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-19.1%
18.05USD 338,481 |
18,750 -19.1% | 18.05 | USD 338,481 | |
| 2023-09-13 | 2023-09-11 | S Sale |
Chief Accounting Officer Officer |
8,750
-33.8%
18.61USD 162,838 |
8,750 -33.8% | 18.61 | USD 162,838 | |
| 2023-09-13 | 2023-09-11 | S Sale |
Chief Accounting Officer Officer |
17,500
-50.5%
18.62USD 325,778 |
17,500 -50.5% | 18.62 | USD 325,778 | |
| 2023-08-16 | 2023-08-15 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-19.1%
18.10USD 339,309 |
18,750 -19.1% | 18.10 | USD 339,309 | |
| 2023-08-16 | 2023-08-14 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-19.1%
18.72USD 351,083 |
18,750 -19.1% | 18.72 | USD 351,083 | |
| 2023-07-14 | 2023-07-13 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-19.1%
16.93USD 317,424 |
18,750 -19.1% | 16.93 | USD 317,424 | |
| 2023-07-14 | 2023-07-12 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-19.1%
16.97USD 318,182 |
18,750 -19.1% | 16.97 | USD 318,182 | |
| 2023-06-16 | 2023-06-15 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-19.1%
18.73USD 351,103 |
18,750 -19.1% | 18.73 | USD 351,103 | |
| 2023-06-16 | 2023-06-14 | PS Planned sale |
Chief Markets Officer Officer |
1,100
-1.4%
19.17USD 21,084 |
1,100 -1.4% | 19.17 | USD 21,084 | |
| 2023-06-16 | 2023-06-14 | PS Planned sale |
Chief Markets Officer Officer |
15,799
-16.6%
18.60USD 293,868 |
15,799 -16.6% | 18.60 | USD 293,868 | |
| 2023-06-16 | 2023-06-14 | PS Planned sale |
Chief Markets Officer Officer |
1,851
-2.3%
17.93USD 33,194 |
1,851 -2.3% | 17.93 | USD 33,194 | |
| 2023-05-18 | 2023-05-18 | S Sale |
CD&R Investment Associates IX, Ltd. Large shareholder |
94,173,804
-48.5%
20.80USD 1,958,937,549 |
94,173,804 -48.5% | 20.80 | USD 1,958,937,549 | |
| 2023-05-17 | 2023-05-16 | PS Planned sale |
Chief Markets Officer Officer |
25,000
-23.9%
23.14USD 578,535 |
25,000 -23.9% | 23.14 | USD 578,535 | |
| 2023-05-17 | 2023-05-15 | PS Planned sale |
Chief Markets Officer Officer |
25,000
-23.9%
23.79USD 594,733 |
25,000 -23.9% | 23.79 | USD 594,733 | |
| 2023-05-11 | 2023-05-09 | PS Planned sale |
Chief Strategy & Dev. Officer Officer |
4,500
-1.5%
26.15USD 117,666 |
4,500 -1.5% | 26.15 | USD 117,666 | |
| 2023-04-21 | 2023-04-20 | PS Planned sale |
Chief Strategy & Dev. Officer Officer |
500
-0.2%
26.15USD 13,074 |
500 -0.2% | 26.15 | USD 13,074 | |
| 2023-04-21 | 2023-04-19 | PS Planned sale |
Chief Strategy & Dev. Officer Officer |
455
-0.2%
27.84USD 12,666 |
455 -0.2% | 27.84 | USD 12,666 | |
| 2023-04-21 | 2023-04-19 | PS Planned sale |
Chief Strategy & Dev. Officer Officer |
4,545
-1.5%
26.82USD 121,877 |
4,545 -1.5% | 26.82 | USD 121,877 | |
| 2023-04-19 | 2023-04-18 | PS Planned sale |
Chief Markets Officer Officer |
25,000
-23.9%
28.05USD 701,130 |
25,000 -23.9% | 28.05 | USD 701,130 | |
| 2023-04-19 | 2023-04-17 | PS Planned sale |
Chief Markets Officer Officer |
1,400
-1.7%
28.54USD 39,957 |
1,400 -1.7% | 28.54 | USD 39,957 | |
| 2023-04-19 | 2023-04-17 | PS Planned sale |
Chief Markets Officer Officer |
23,600
-22.6%
27.70USD 653,640 |
23,600 -22.6% | 27.70 | USD 653,640 | |
| 2023-03-27 | 2023-03-24 | PS Planned sale |
Chief Strategy & Dev. Officer Officer |
97,290
-26.0%
28.70USD 2,792,379 |
97,290 -26.0% | 28.70 | USD 2,792,379 | |
| 2023-03-27 | 2023-03-23 | PS Planned sale |
Chief Strategy & Dev. Officer Officer |
22,710
-7.6%
28.71USD 651,911 |
22,710 -7.6% | 28.71 | USD 651,911 | |
| 2023-03-24 | 2023-03-23 | PS Planned sale |
Chief Med. & Quality Officer Officer |
8,094
-12.7%
28.04USD 226,978 |
8,094 -12.7% | 28.04 | USD 226,978 | |
| 2023-03-24 | 2023-03-22 | PS Planned sale |
Chief Med. & Quality Officer Officer |
8,094
-12.7%
27.84USD 225,376 |
8,094 -12.7% | 27.84 | USD 225,376 | |
| 2023-03-17 | 2023-03-16 | PS Planned sale |
Chief Markets Officer Officer |
10,581
-14.9%
26.08USD 275,965 |
10,581 -14.9% | 26.08 | USD 275,965 | |
| 2023-03-17 | 2023-03-16 | PS Planned sale |
Chief Markets Officer Officer |
9,831
-12.1%
25.65USD 252,192 |
9,831 -12.1% | 25.65 | USD 252,192 | |
| 2023-03-17 | 2023-03-16 | PS Planned sale |
Chief Markets Officer Officer |
4,588
-5.4%
24.36USD 111,741 |
4,588 -5.4% | 24.36 | USD 111,741 | |
| 2023-03-17 | 2023-03-16 | PS Planned sale |
Chief Strategy & Dev. Officer Officer |
60,000
-17.8%
26.09USD 1,565,196 |
60,000 -17.8% | 26.09 | USD 1,565,196 | |
| 2023-03-17 | 2023-03-15 | PS Planned sale |
Chief Markets Officer Officer |
25,000
-29.2%
23.80USD 595,075 |
25,000 -29.2% | 23.80 | USD 595,075 | |
| 2023-03-17 | 2023-03-15 | S Sale |
Chief Markets Officer Officer |
35,000
-29.0%
23.81USD 833,231 |
35,000 -29.0% | 23.81 | USD 833,231 | |
| 2023-03-17 | 2023-03-15 | S Sale | Non-Executive Director |
80,000
-39.3%
23.82USD 1,905,224 |
80,000 -39.3% | 23.82 | USD 1,905,224 | |
| 2023-03-17 | 2023-03-15 | S Sale |
Chief Med. & Quality Officer Officer |
55,000
-49.8%
23.81USD 1,309,424 |
55,000 -49.8% | 23.81 | USD 1,309,424 | |
| 2023-03-09 | 2023-03-08 | PS Planned sale |
Chief Med. & Quality Officer Officer |
8,094
-43.7%
24.44USD 197,821 |
8,094 -43.7% | 24.44 | USD 197,821 | |
| 2023-03-09 | 2023-03-07 | PS Planned sale |
Chief Med. & Quality Officer Officer |
8,094
-43.7%
24.36USD 197,197 |
8,094 -43.7% | 24.36 | USD 197,197 | |
| 2023-02-16 | 2023-02-15 | PS Planned sale |
Chief Markets Officer Officer |
28,555
-52.7%
23.37USD 667,342 |
28,555 -52.7% | 23.37 | USD 667,342 | |
| 2023-02-16 | 2023-02-15 | PS Planned sale |
Chief Med. & Quality Officer Officer |
8,094
-43.7%
22.98USD 186,028 |
8,094 -43.7% | 22.98 | USD 186,028 | |
| 2023-02-16 | 2023-02-14 | PS Planned sale |
Chief Markets Officer Officer |
50,000
-66.1%
22.98USD 1,149,060 |
50,000 -66.1% | 22.98 | USD 1,149,060 | |
| 2023-02-16 | 2023-02-14 | PS Planned sale |
Chief Med. & Quality Officer Officer |
25,881
-71.3%
22.99USD 594,877 |
25,881 -71.3% | 22.99 | USD 594,877 | |
| 2023-02-03 | 2023-02-02 | PS Planned sale |
Chief Med. & Quality Officer Officer |
30,782
-74.7%
22.99USD 707,561 |
30,782 -74.7% | 22.99 | USD 707,561 | |
| 2023-02-03 | 2023-02-01 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,396
-34.1%
21.76USD 117,420 |
5,396 -34.1% | 21.76 | USD 117,420 | |
| 2023-01-23 | 2023-01-20 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,396
-34.1%
19.92USD 107,496 |
5,396 -34.1% | 19.92 | USD 107,496 | |
| 2023-01-23 | 2023-01-19 | PS Planned sale |
Chief Med. & Quality Officer Officer |
10,792
-50.9%
19.73USD 212,943 |
10,792 -50.9% | 19.73 | USD 212,943 | |
| 2023-01-19 | 2023-01-18 | PS Planned sale |
Chief Markets Officer Officer |
20,723
-44.7%
19.78USD 409,889 |
20,723 -44.7% | 19.78 | USD 409,889 | |
| 2023-01-19 | 2023-01-17 | PS Planned sale |
Chief Markets Officer Officer |
25,722
-50.1%
19.91USD 512,225 |
25,722 -50.1% | 19.91 | USD 512,225 | |
| 2023-01-09 | 2023-01-06 | PS Planned sale |
Chief Med. & Quality Officer Officer |
2,698
-20.6%
15.46USD 41,702 |
2,698 -20.6% | 15.46 | USD 41,702 | |
| 2023-01-09 | 2023-01-05 | PS Planned sale |
Chief Med. & Quality Officer Officer |
2,698
-20.6%
15.51USD 41,845 |
2,698 -20.6% | 15.51 | USD 41,845 | |
| 2022-12-19 | 2022-12-16 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,398
-34.1%
16.82USD 90,807 |
5,398 -34.1% | 16.82 | USD 90,807 | |
| 2022-12-19 | 2022-12-15 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,398
-34.1%
17.42USD 94,013 |
5,398 -34.1% | 17.42 | USD 94,013 | |
| 2022-12-16 | 2022-12-15 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-42.3%
17.26USD 323,663 |
18,750 -42.3% | 17.26 | USD 323,663 | |
| 2022-12-16 | 2022-12-14 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-42.3%
17.52USD 328,491 |
18,750 -42.3% | 17.52 | USD 328,491 | |
| 2022-12-07 | 2022-12-06 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,398
-34.1%
17.72USD 95,632 |
5,398 -34.1% | 17.72 | USD 95,632 | |
| 2022-12-07 | 2022-12-05 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,398
-34.1%
17.80USD 96,079 |
5,398 -34.1% | 17.80 | USD 96,079 | |
| 2022-11-22 | 2022-11-18 | B Purchase |
CEO & President Executive Director |
2,900
+inf%
17.14USD 49,705 |
2,900 +inf% | 17.14 | USD 49,705 | |
| 2022-11-18 | 2022-11-17 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,396
-34.1%
17.43USD 94,055 |
5,396 -34.1% | 17.43 | USD 94,055 | |
| 2022-11-18 | 2022-11-17 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-42.3%
17.17USD 321,956 |
18,750 -42.3% | 17.17 | USD 321,956 | |
| 2022-11-18 | 2022-11-16 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,396
-34.1%
18.52USD 99,919 |
5,396 -34.1% | 18.52 | USD 99,919 | |
| 2022-11-18 | 2022-11-16 | PS Planned sale |
Chief Markets Officer Officer |
18,750
-42.3%
18.29USD 343,009 |
18,750 -42.3% | 18.29 | USD 343,009 | |
| 2022-11-03 | 2022-11-02 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,396
-34.1%
19.53USD 105,407 |
5,396 -34.1% | 19.53 | USD 105,407 | |
| 2022-11-03 | 2022-11-01 | PS Planned sale |
Chief Med. & Quality Officer Officer |
5,396
-34.1%
20.03USD 108,093 |
5,396 -34.1% | 20.03 | USD 108,093 | |
| 2022-10-21 | 2022-10-20 | S Sale |
Chief Markets Officer Officer |
1,500
-5.5%
20.66USD 30,991 |
1,500 -5.5% | 20.66 | USD 30,991 |